Clinical Trial

COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)

Study acronym: FRII
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This 2-arm clustered, randomized community trial will test a multilevel, religiously-tailored COVID-19 rapid, self-testing and treatment intervention against a nontailored, education condition on uptake of COVID-19 rapid testing with 900 adult African American church members and community members using outreach ministry services from 12 churches at 6 months. Rapid COVID-19 self-testing and contact tracing (beliefs and practices), and use of linkage to care services (e.g., referrals to treatment, health insurance, medical home/appointments, community resources) will also be examined. Findings from this study could provide a scalable model for feasible, accessible and acceptable COVID-19 rapid, self-testing (with rapid linkage to treatment and health/community resources) in public (churches and their affiliate settings and organizations), home, and health provider spaces by equipping African American churches with culturally-appropriate, easy-to-use rapid test kits, health department support, and tailored COVID-19 test-to-treat education and promotion tools.
Trial Details
NCT Number NCT07450209
Lead Sponsor University of Missouri, Kansas City
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions COVID-19 Testing Behaviors
Enrollment 900 participants
Start Date 2024-05-15
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-04